Condition: Bladder Cancer · Sponsor: Kyoto University Hospital
This study is designed to assess the efficacy and safety of induction therapy with MK-3475 and ASG-22CE and radiation therapy with MK-3475 in patients with cT2-4aN0M0 muscle invasive bladder cancer who are unfit for or refuse radical cystectomy.
This description comes directly from the study's public registry record.
Yuki Kita, MD,PhD · 81757513337 · kitayuki@kuhp.kyoto-u.ac.jp
Always discuss trial participation with your own doctor first.
| Kobe City Medical Center General Hospital | Kobe, Hyōgo, Japan | Recruiting |
| University of Tsukuba Hospital | Tsukuba, Ibaraki, Japan | Recruiting |
| Kyoto University Hospital | Kyoto, Kyoto, Japan | Recruiting |
| Osaka Metropolitan University Hospital | Osaka, Osaka, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05879653